Cargando…

Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system

Background: Methylphenidate, atomoxetine, and Amphetamine are the three most commonly used medications approved by the United States Food and Drug Administration (FDA) for the treatment of attention deficit/hyperactivity disorder (ADHD). However, a comprehensive analysis of their safety profiles acr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Wei, Chen, Li, Zhou, Hui, Liu, Jinfeng, Zhang, Yue, Feng, Shiyu, Bai, Yingtao, Leng, Yanen, Chang, En, Huang, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461182/ https://www.ncbi.nlm.nih.gov/pubmed/37645441 http://dx.doi.org/10.3389/fphar.2023.1208456

Ejemplares similares

Characterization of Amphetamine, Methylphenidate, Nicotine, and Atomoxetine on Measures of Attention, Impulsive Action, and Motivation in the Rat: Implications for Translational Research
por: Higgins, Guy A., et al.
Publicado: (2020)

Adverse Event Profiles of PARP Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS
por: Tian, Xiaojiang, et al.
Publicado: (2022)

Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy
por: Bro, Søren Pauli, et al.
Publicado: (2015)

Commentary: Adverse event profiles of PARP inhibitors: analysis of spontaneous reports submitted to FAERS
por: Schilder, Jeanne M., et al.
Publicado: (2023)

Atomoxetine/Methylphenidate Effects on Social Play Behavior
por: Millichap, J. Gordon
Publicado: (2015)

Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults
por: Schelleman, Hedi, et al.
Publicado: (2013)

Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
por: Fenderson, Joshua L., et al.
Publicado: (2013)

Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine
por: Hennissen, Leonie, et al.
Publicado: (2017)

Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
por: Suzuki, Shiho, et al.
Publicado: (2020)

Transition from Methylphenidate to Atomoxetine: reasons for switching and clinical outcome
por: Cassar, Fabrizia, et al.
Publicado: (2021)

Methylphenidate-induced Exacerbation of Chorea in a Child Resolved with Switching to Atomoxetine
por: Ekinci, Ozalp, et al.
Publicado: (2020)

Mining Patients' Narratives in Social Media for Pharmacovigilance: Adverse Effects and Misuse of Methylphenidate
por: Chen, Xiaoyi, et al.
Publicado: (2018)

Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
por: Bai, Xiaoyin, et al.
Publicado: (2021)

Cosmetics and Cancer: Adverse Event Reports Submitted to the Food and Drug Administration
por: Jacob, Saya L, et al.
Publicado: (2018)

Atomoxetine might be more effective in improving sluggish cognitive tempo symptoms after switching from methylphenidate: A case report
por: Tahıllıoğlu, Akın, et al.
Publicado: (2020)

Shared and Unique Effects of Long-Term Administration of Methylphenidate and Atomoxetine on Degree Centrality in Medication-Naïve Children With Attention-Deficit/Hyperactive Disorder
por: Fu, Zhao, et al.
Publicado: (2022)

Differential Influence of Dopamine Transport Rate on the Potencies of Cocaine, Amphetamine, and Methylphenidate
por: Calipari, Erin S., et al.
Publicado: (2014)

Amphetamine, but not methylphenidate, increases ethanol intake in adolescent male, but not in female, rats
por: Ruiz, Paul, et al.
Publicado: (2018)

Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorder
por: Garg, Jasmin, et al.
Publicado: (2015)

Methylphenidate and atomoxetine prescribing trends in children in the Western Cape Province of South Africa, 2005–2013
por: Joubert, Liezl, et al.
Publicado: (2018)

Systematic Review of Suicidal Behaviors Related to Methylphenidate and Atomoxetine in Patients With Attention Deficit Hyperactivity Disorder
por: Kim, Jae Heon, et al.
Publicado: (2023)

Amphetamine Derivatives as Monoamine Oxidase Inhibitors
por: Reyes-Parada, Miguel, et al.
Publicado: (2020)

Amphetamine Promotes Cortical Up State in Part Via Dopamine Receptors
por: Shen, Guofang, et al.
Publicado: (2021)

Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression
por: Calipari, Erin S., et al.
Publicado: (2013)

Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States
por: Vaddadi, Sneha M., et al.
Publicado: (2021)

Pattern Classification of Working Memory Networks Reveals Differential Effects of Methylphenidate, Atomoxetine, and Placebo in Healthy Volunteers
por: Marquand, Andre F, et al.
Publicado: (2011)

Shared and Drug-Specific Effects of Atomoxetine and Methylphenidate on Inhibitory Brain Dysfunction in Medication-Naive ADHD Boys
por: Cubillo, Ana, et al.
Publicado: (2014)

Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects
por: Fujioka, Toru, et al.
Publicado: (2016)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
por: Joseph, Alain, et al.
Publicado: (2016)

Single-dose effects of methylphenidate and atomoxetine on functional connectivity during an n-back task in boys with ADHD
por: Kowalczyk, Olivia S., et al.
Publicado: (2023)

Block of Voltage-Gated Sodium Channels by Atomoxetine in a State- and Use-dependent Manner
por: Föhr, Karl Josef, et al.
Publicado: (2021)

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder
por: Carlson, Gabrielle A, et al.
Publicado: (2007)

A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain
por: Hong, Jihyung, et al.
Publicado: (2009)

Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy
por: Nakanishi, Yoko, et al.
Publicado: (2017)

Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System
por: Dores, Graça M., et al.
Publicado: (2019)

Single and Repeated Administration of Methylphenidate Modulates Synaptic Plasticity in Opposite Directions via Insertion of AMPA Receptors in Rat Hippocampal Neurons
por: Carvallo, Claudia, et al.
Publicado: (2018)

Atomoxetine in abstinent cocaine users: Sex differences
por: DeVito, Elise E., et al.
Publicado: (2017)

Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2019)

Analysis of spontaneous reports of suspected adverse reactions after vaccination against COVID-19 in Slovakia
por: Lassanova, Monika, et al.
Publicado: (2023)

Gender differences in spontaneous adverse event reports associated with zolpidem in South Korea, 2015–2019
por: Joung, Kyung-In
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ureiun3s5irsnr9tdqdg3j8m65